OncLive.com
@OncLive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
Exciting news! 📣 OncLive Insider is now available for iPhone and Android users. From breaking news to AI-powered search and content you can save for later, it’s the easiest way to stay connected to the field. 📱 Click here to learn more: hubs.li/Q03wFmww0
Huge thank you to @BalazsHalmosM, of @MontefioreNYC, for stopping by at #BTGLung2025 to discuss disease progression in patients on neoadjuvant #LungCancer! Check out our site for more from the meeting! #lcsm #Oncology onclive.com/bridging-the-g…
Thanks to @DrRaviSalgia, of @cityofhopeoc, for stopping by during #BTGLung2025 to highlight emerging treatment options in #SCLC! #lcsm #Oncology onclive.com/bridging-the-g…
Great chairing and real commitment to keeping us on time at #BTGLung2025 @OncLive
Diving beyond EGFR in NSCLC with an excellent session chaired by @SchenkLab, featuring a stellar lineup of talks on KRAS, BRAF, ROS1, MET, RET, and more! With insights from @christinemphmd @drgandara @mihaela_aldea @nievamd @riess_md @OncLive #BTGLung2025 #LCSM #Oncology
At #BTGLung, we also spoke with @FawziAbuRous of @HenryFordHealth about treatment options for patients who progress on immunotherapy in #NSCLC. Watch the clip below for a quick look at our conversation, and check out onclive.com to learn more. #lcsm #oncology
WATCH: Jorge Nieva, MD, discusses matched-adjusted indirect comparison data evaluating crizotinib vs alectinib, brigatinib, and lorlatinib in ALK-positive NSCLC. @nievamd @KECKSchool_USC #BTGLung2025 #lcsm #oncology onclive.com/view/dr-nieva-…
Hear @ElaineShumMD of @nyulangone preview top takeaways from her #BTGLung presentation on questions and considerations for first-line treatment selection in EGFR+ #NSCLC! 🫁 Want to learn more? Check back at onclive.com for her full insights. @gotoPER #lcsm
WATCH: Sandip P. Patel, MD, discusses toxicities associated with the use of immunotherapy-based combination regimens in patients with advanced NSCLC. @PatelOncology @UCSDHealth #BTGLung2025 #lcsm #Oncology onclive.com/view/dr-patel-…
Thank you to Dr Jonathan Riess, of @UCD_Cancer, for sitting down with us at #BTGLung2025 to discuss the management of KRAS and BRAF mutations in NSCLC! See our site for more from the meeting! #lcsm #oncology onclive.com/bridging-the-g…
A huge thanks to @nievamd, of @KECKSchool_USC, who stopped by during #BTGLung2025 to talk about the management of ALK rearrangements in NSCLC! Check out our site for exclusive insights from Dr Nieva and more! #lcsm #oncology onclive.com/bridging-the-g…
In the 1st episode of Cancer, Character, and Calling: The Oncologist's Journey, Girindra Raval, MD, sits down with @GCC_Cortes to discuss Cortes' experiences during his journey through the hematologic oncology field @GACancerCenter #oncology Listen now: onclive.com/view/cortes-jo…
Thank you to @triparnasen for joining us at #BTGLung2025 to talk about biomarkers and classification in SCLC! Head to our site for exclusive meeting commentary from Sen and more! #lcsm #Oncology onclive.com/bridging-the-g…
A huge thanks to @NarjustFlorezMD of @danafarber, the chair of #BTGLung2025, who joined us for an interview to discuss highlights from the meeting. Head to our site for more from the meeting! #lcsm #oncology
🔴WE ARE LIVE! Tune In NOW! OncLive's "Bridging the Gaps in Lung Cancer" is officially LIVE! Join Narjust Florez, MD, Edward S. Kim, MD, & Eric K. Singhi, MD for interactive polls & discussion. Your input shapes the conversation! #BTGLung2025 @lungoncdoc @DrEdKim @NarjustFlorezMD
Polling Q9. IO in NSCLC‼️ What’s the most promising therapeutic approach to overcome immune checkpoint inhibitor resistance? #BTGLung2025 @OncLive @NarjustFlorezMD @DrEdKim
We'll be live within the next 15 minutes for our #BTGLung2025 livestream with @NarjustFlorezMD, @DrEdKim, and @lungoncdoc discussing the results of the community polling questions! See you soon! #lcsm #oncology
Hear @DrEdKim, one of the co-chairs of #BTGLung2025, summarize highlights from the meeting that show why you should tune into today's livestreamed discussion happening at 3:30pm PT! @cityofhope #lcsm #oncology
Dr. @FawziAbuRous provides a “roadmap” for management after progression on immunotherapy. #BTGLung2025 @OncLive
Dr. @PatelOncology offers his thoughts on the 1L management of mNSCLC BOOKMARK this slide. #BTGLung2025 @OncLive @NarjustFlorezMD @DrEdKim
TQB2930 Plus Chemo Drives Responses in Pretreated HER2+ Metastatic Breast Cancer #oncology #bcsm hubs.li/Q03yDjFj0